Michael A. Allon, MPPA – FDA 483, Jun 1, 2026

Michael A. Allon, M.D, P.A. in Houston, TX, a reproductive tissue establishment, was cited for significant deficiencies in donor screening and eligibility determination for HCT/P donors. The inspection revealed failures to adequately screen donors for communicable disease risk factors, maintain complete and accurate donor records, and establish compliant procedures for donor eligibility and record-keeping. These issues indicate a systemic lack of control over critical processes for ensuring donor safety.